Patent · US Active

Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications

US11091543B2 · kind B2 · utility

2Cited by

14References

9Claims

0Family size

Assignee

SWEDISH ORPHAN BIOVITRUM AG · SE

Inventors

Cristina DE MIN · Geneva, CH
Walter Ferlin · Annemasse, FR
Fabrizio De Benedetti · Geneva, CH

Key dates

Filing date	Oct 24, 2017
Grant date	Aug 17, 2021
Priority date	—
Expiry date	Jul 17, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure relates generally to methods compositions and dosing regimens for treating, preventing and/or delaying the onset or progression of, or alleviating a symptom associated with elevated IFN-γ levels.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.